⌘K

AbbVie Inc. (ABBV)

$143.41 0.72% $1.02 Healthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Market cap

$253.20B

CEO

Mr. Richard A. Gonzalez

Full time employees

50,000.00

Headquarters

North Chicago, IL

IPO Date

Jan 02, 2013

Price-to-earnings (PE) Ratio

39.18

Earnings-per-share (EPS)

$3.66

Cash ratio (TTM)

0.38

Current ratio (TTM)

0.96

Dividend yield (TTM)

4.16%

Earnings yield (TTM)

2.59%

Net profit margin (TTM)

11.81%

PE ratio (TTM)

38.58

PEG ratio (TTM)

0.21

Price-to-book ratio (TTM)

20.78

Price-to-sales ratio (TTM)

4.56

Quick ratio (TTM)

0.71

Return on assets (TTM)

4.78%

Return on equity (TTM)

46.96%

Similar stocks (7)

Eli Lilly and Company

LLY

$584.04 -1.18% $-7.00

Uptrend

Johnson & Johnson

JNJ

$158.38 2.41% $3.72

Downtrend

Merck & Co., Inc.

MRK

$103.46 0.96% $0.98

Downtrend

Pfizer Inc.

PFE

$28.91 -5.12% $-1.56

Downtrend

Amgen Inc.

AMGN

$272.45 1.04% $2.81

Uptrend

Bristol-Myers Squibb Company

BMY

$50.10 1.46% $0.72

Downtrend

Gilead Sciences, Inc.

GILD

$77.65 1.37% $1.05

Downtrend

ETF Exposure (36)

Enact Holdings, Inc.

ACT

6.49%

$27.90 0.69% $0.19

Uptrend

Invesco Dynamic Pharmaceuticals ETF

PJP

5.812%

$71.39 0.89% $0.63

Downtrend

Health Care Select Sector SPDR Fund

XLV

5.15347%

$131.83 0.40% $0.52

Neutral

iShares U.S. Healthcare ETF

IYH

4.97188%

$275.65 0.50% $1.36

Downtrend

VanEck Pharmaceutical ETF

PPH

4.92%

$78.72 0.27% $0.21

Downtrend

Vanguard Health Care Index Fund

VHT

4.76%

$240.15 0.65% $1.55

Downtrend

iShares Global Healthcare ETF

IXJ

3.67389%

$84.06 0.39% $0.33

Downtrend

Invesco Dynamic Large Cap Value ETF

PWV

3.381%

$48.75 0.77% $0.37

Uptrend

Vanguard Value Index Fund

VTV

1.53%

$144.53 0.89% $1.27

Neutral

Vanguard S&P 500 Growth Index Fund

VOOG

1.29%

$262.81 0.35% $0.92

Uptrend

SPDR Portfolio S&P 500 Growth ETF

SPYG

1.202114%

$63.12 0.37% $0.23

Uptrend

iShares S&P 500 Growth ETF

IVW

1.20108%

$72.84 0.36% $0.26

Uptrend

iShares MSCI USA Quality Factor ETF

QUAL

1.17407%

$141.91 0.60% $0.84

Uptrend

iShares Core S&P U.S. Growth ETF

IUSG

1.13408%

$100.86 0.48% $0.48

Uptrend

iShares Russell 1000 Growth ETF

IWF

1.0982%

$291.97 0.38% $1.11

Uptrend

iShares S&P 100 ETF

OEF

0.96003%

$216.18 0.26% $0.56

Uptrend

Vanguard Large Cap Index Fund

0.69%

$210.88 0.60% $1.25

Uptrend

Pacer Trendpilot US Large Cap ETF

PTLC

0.66%

$42.16 0.57% $0.24

Uptrend

SPDR S&P 500 ETF Trust

SPY

0.654067%

$459.10 0.59% $2.70

Uptrend

iShares Core S&P 500 ETF

IVV

0.65393%

$461.13 0.59% $2.71

Uptrend

First Trust Value Line Dividend Index Fund

FVD

0.63%

$39.50 1.36% $0.53

Downtrend

SPDR Global Dow ETF

DGT

0.61889%

$115.57 0.80% $0.92

Neutral

iShares Morningstar U.S. Equity ETF

ILCB

0.61667%

$63.43 0.63% $0.40

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0.61%

$111.09 0.85% $0.94

Uptrend

Vanguard Total Stock Market Index Fund

VTI

0.61%

$228.17 0.84% $1.91

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0.61%

$111.07 0.85% $0.94

Uptrend

SPDR Portfolio S&P 1500 Composite Stock Market ETF

SPTM

0.600341%

$56.29 0.77% $0.43

Uptrend

iShares Russell 1000 ETF

IWB

0.59594%

$252.61 0.76% $1.90

Uptrend

iShares Dow Jones U.S. ETF

IYY

0.59106%

$112.18 0.70% $0.78

Uptrend

iShares Russell 3000 ETF

IWV

0.56609%

$263.04 0.81% $2.11

Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.56432%

$101.14 0.82% $0.82

Uptrend

iShares MSCI Global Min Vol Factor ETF

ACWV

0.46919%

$99.25 0.49% $0.48

Neutral

iShares MSCI World ETF

URTH

0.43593%

$128.76 0.77% $0.98

Uptrend

Invesco S&P 500 Equal Weight ETF

RSP

0.189%

$150.53 1.50% $2.23

Neutral

iShares MSCI USA Equal Weighted ETF

EUSA

0.16617%

$80.23 1.61% $1.27

Neutral

JPMorgan Ultra-Short Income ETF

JPST

$50.16 0.08% $0.04

Neutral